OSIR

Osiris Therapeutics, Inc. News Headlines

$14.87
*  
0.13
0.88%
Get OSIR Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading OSIR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Cell Therapy 2015: With Maturity Comes Promise
12/24/2014 7:41:00 AM - Seeking Alpha


Stryker & Osiris Team Up to Market Viable Bone Matrix - Analyst Blog
12/23/2014 3:50:00 PM - Zacks.com


Stryker & Osiris Team Up to Market Viable Bone Matrix - Analyst Blog
12/23/2014 3:50:00 AM - Investopedia


Is Osiris Therapeutics (OSIR) Stock a Solid Choice Right Now? - Tale of the Tape
12/5/2014 8:34:00 AM - Zacks.com


Osiris Names Adrian Mollo General Counsel - Quick Facts
12/3/2014 8:25:00 AM - RTT News


Osiris Therapeutics Beats on Q3 Earnings & Revenues - Analyst Blog
11/11/2014 9:00:00 AM - Zacks.com


Osiris Swings To Profit
11/7/2014 1:18:00 PM - RTT News


Osiris Therapeutics Q3 14 Earnings Conference Call At 9:00 AM ET
11/7/2014 8:00:00 AM - RTT News


Japan Gives A Hug To The Cell Therapy Industry: R. Lee Buckler
10/24/2014 8:21:00 AM - Seeking Alpha


Need knee repair? Histogenics files for a $65 million IPO
10/7/2014 6:04:13 PM - Renaissance Capital


Avita Medical: A Comprehensive Look At An Unknown Company With A Transcendent Technology
10/7/2014 1:35:00 PM - Seeking Alpha


Update: Osiris Therapeutics Earnings
8/15/2014 8:55:00 AM - Seeking Alpha


Osiris Falls despite Narrower Q2 Loss and Higher Revenues - Analyst Blog
8/11/2014 10:50:00 AM - Zacks.com


Arena Pharmaceuticals-Eisai Boost Obesity Drug Sales Force - Analyst Blog
7/11/2014 3:45:00 PM - Zacks.com


Osiris Therapeutics' Survival In Doubt After Losing 'Pass-Through' Status In 2015
7/11/2014 11:56:00 AM - Seeking Alpha


Lexicon (LXRX) Jumps: Stock Moves 7.6% Higher - Tale of the Tape
7/10/2014 8:46:00 AM - Zacks.com


BIND Therapeutics (BIND) in Focus: Stock Tumbles 10.0% - Tale of the Tape
7/7/2014 7:44:00 AM - Zacks.com


Merge Healthcare: Updated Research Report - Analyst Blog
6/20/2014 1:55:00 PM - Zacks.com


Illumina: Updated Research Report - Analyst Blog
6/20/2014 1:30:00 PM - Zacks.com


Geron Gains as FDA Lifts Partial Hold on Imetelstat Study - Analyst Blog
6/13/2014 12:10:00 PM - Zacks.com


Orexigen Therapeutics (OREX) in Focus: Stock Tumbles 14.7% - Tale of the Tape
6/12/2014 7:56:00 AM - Zacks.com


Biogen's Eloctate Approved in the U.S. - Analyst Blog
6/9/2014 12:50:00 PM - Zacks.com


Isis Pharma Gains on Mid-Stage Data - Analyst Blog
5/23/2014 12:50:00 PM - Zacks.com


Can the Rally in Osiris (OSIR) Shares Continue? - Tale of the Tape
5/20/2014 9:31:20 AM - Zacks.com


Increased Earnings Estimates Seen for Osiris (OSIR): Can It Move Higher? - Tale of the Tape
5/16/2014 7:47:00 AM - Zacks.com